Pang, H., Yan, M., Chen, X., & Sun, H. Combination of trastuzumab and pertuzumab with FOLFOXIRI as the neoadjuvant therapeutic tegimen for HER2-positive resectable metastatic colorectal cancer: The first case report. Elsevier.
Chicago Style (17th ed.) CitationPang, Hua-Yang, Meng-Yua Yan, Xiu-Feng Chen, and Hao Sun. Combination of Trastuzumab and Pertuzumab with FOLFOXIRI as the Neoadjuvant Therapeutic Tegimen for HER2-positive Resectable Metastatic Colorectal Cancer: The First Case Report. Elsevier.
MLA (9th ed.) CitationPang, Hua-Yang, et al. Combination of Trastuzumab and Pertuzumab with FOLFOXIRI as the Neoadjuvant Therapeutic Tegimen for HER2-positive Resectable Metastatic Colorectal Cancer: The First Case Report. Elsevier.
Warning: These citations may not always be 100% accurate.